Zoom Video Communications (ZM) 10-Q23 Nov 222023 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Oct. 31, 2022	Nov. 11, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-38865
Entity Registrant Name	Zoom Video Communications, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	61-1648780
Entity Address, Address Line One	55 Almaden Boulevard, 6th Floor
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95113
City Area Code	888
Local Phone Number	799-9666
Title of 12(b) Security	Class A Common Stock, $0.001 par value per share
Trading Symbol	ZM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001585521
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		245,652,118
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		46,670,111

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,096,174	$ 1,062,820
Marketable securities	4,068,818	4,356,446
Accounts receivable, net of allowances of $35,033 and $24,696 as of October 31, 2022 and January 31, 2022, respectively	589,573	419,673
Deferred contract acquisition costs, current	221,871	199,266
Prepaid expenses and other current assets	165,661	145,602
Total current assets	6,142,097	6,183,807
Deferred contract acquisition costs, noncurrent	173,305	164,714
Property and equipment, net	250,843	222,354
Operating lease right-of-use assets	90,981	95,965
Strategic investments	354,549	367,814
Goodwill	122,556	27,607
Deferred tax assets	550,539	382,296
Other assets, noncurrent	152,308	106,761
Total assets	7,837,178	7,551,318
Current liabilities:
Accounts payable	27,247	7,841
Accrued expenses and other current liabilities	561,300	430,415
Deferred revenue, current	1,307,763	1,141,435
Total current liabilities	1,896,310	1,579,691
Deferred revenue, noncurrent	46,460	38,481
Operating lease liabilities, noncurrent	78,128	85,018
Other liabilities, noncurrent	60,468	68,110
Total liabilities	2,081,366	1,771,300
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.001 par value per share, 200,000,000 shares authorized as of October 31, 2022 and January 31, 2022; zero shares issued and outstanding as of October 31, 2022 and January 31, 2022	0	0
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of October 31, 2022 and January 31, 2022; 246,009,355 and 247,044,454 shares issued and outstanding as of October 31, 2022 and January 31, 2022, respectively; 300,000,000 Class B shares authorized as of October 31, 2022 and January 31, 2022; 46,309,998 and 51,993,351 shares issued and outstanding as of October 31, 2022 and January 31, 2022, respectively	292	299
Additional paid-in capital	3,572,368	3,749,514
Accumulated other comprehensive loss	(72,716)	(17,902)
Retained earnings	2,255,868	2,048,107
Total stockholders’ equity	5,755,812	5,780,018
Total liabilities and stockholders’ equity	$ 7,837,178	$ 7,551,318

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Current assets:
Accounts receivable, allowances	$ 35,033	$ 24,696
Stockholders’ equity:
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	200,000,000	200,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Class A Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, issued (in shares)	246,009,355	247,044,454
Common stock, outstanding (in shares)	246,009,355	247,044,454
Class B Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	300,000,000	300,000,000
Common stock, issued (in shares)	46,309,998	51,993,351
Common stock, outstanding (in shares)	46,309,998	51,993,351

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Statement [Abstract]
Revenue	$ 1,101,899	$ 1,050,756	$ 3,275,157	$ 3,028,488
Cost of revenue	270,665	270,957	806,097	797,207
Gross profit	831,234	779,799	2,469,060	2,231,281
Operating expenses:
Research and development	195,946	98,508	512,801	245,994
Sales and marketing	427,747	293,698	1,191,004	810,544
General and administrative	141,033	96,736	389,939	362,971
Total operating expenses	764,726	488,942	2,093,744	1,419,509
Income from operations	66,508	290,857	375,316	811,772
(Losses) gains on strategic investments, net	(6,898)	122,421	(78,014)	154,497
Other expense, net	(4,861)	(2,995)	(8,482)	(3,171)
Income before provision for income taxes	54,749	410,283	288,820	963,098
Provision for income taxes	6,396	69,900	81,059	78,100
Net income	48,353	340,383	207,761	884,998
Undistributed earnings attributable to participating securities	0	(112)	(17)	(430)
Net income attributable to common stockholders	$ 48,353	$ 340,271	$ 207,744	$ 884,568
Net income per share attributable to common stockholders:
Basic (in dollars per share)	$ 0.16	$ 1.14	$ 0.70	$ 2.99
Diluted (in dollars per share)	$ 0.16	$ 1.11	$ 0.68	$ 2.89
Weighted-average shares used in computing net income per share attributable to common stockholders:
Basic (in shares)	295,537,026	297,375,011	297,765,848	295,647,626
Diluted (in shares)	301,986,341	305,939,624	305,273,812	305,726,733

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 48,353	$ 340,383	$ 207,761	$ 884,998
Other comprehensive loss:
Unrealized loss on available-for-sale marketable securities, net of tax	(24,555)	(5,275)	(54,814)	(5,967)
Comprehensive income	$ 23,798	$ 335,108	$ 152,947	$ 879,031

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Jan. 31, 2021		293,549,223
Beginning balance at Jan. 31, 2021	$ 3,860,767	$ 292	$ 3,187,168	$ 839	$ 672,468
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		2,205,249
Issuance of common stock upon exercise of stock options	11,362	$ 3	11,359
Issuance of common stock upon release of restricted stock units (in shares)		1,480,536
Issuance of common stock upon release of restricted stock units	1	$ 1
Issuance of common stock for employee stock purchase plan (in shares)		701,949
Issuance of common stock for employee stock purchase plan	37,846	$ 1	37,845
Stock-based compensation expense	324,678		324,678
Other comprehensive loss	(5,967)			(5,967)
Net income	884,998				884,998
Ending balance (in shares) at Oct. 31, 2021		297,936,957
Ending balance at Oct. 31, 2021	5,113,685	$ 297	3,561,050	(5,128)	1,557,466
Beginning balance (in shares) at Jul. 31, 2021		297,027,323
Beginning balance at Jul. 31, 2021	4,657,748	$ 296	3,440,222	147	1,217,083
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		612,056
Issuance of common stock upon exercise of stock options	3,125	$ 1	3,124
Issuance of common stock upon release of restricted stock units (in shares)		297,578
Issuance of common stock upon release of restricted stock units	0	$ 0
Stock-based compensation expense	117,704		117,704
Other comprehensive loss	(5,275)			(5,275)
Net income	340,383				340,383
Ending balance (in shares) at Oct. 31, 2021		297,936,957
Ending balance at Oct. 31, 2021	5,113,685	$ 297	3,561,050	(5,128)	1,557,466
Beginning balance (in shares) at Jan. 31, 2022		299,037,805
Beginning balance at Jan. 31, 2022	$ 5,780,018	$ 299	3,749,514	(17,902)	2,048,107
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,087,238	1,087,238
Issuance of common stock upon exercise of stock options	$ 7,052	$ 1	7,051
Issuance of common stock upon release of restricted stock units (in shares)		2,865,551
Issuance of common stock upon release of restricted stock units	0	$ 3	(3)
Issuance of common stock for employee stock purchase plan (in shares)		373,259
Issuance of common stock for employee stock purchase plan	34,604		34,604
Repurchase of common stock (in shares)		(11,044,500)
Repurchase of common stock	(990,778)	$ (11)	(990,767)
Stock-based compensation expense	771,969		771,969
Other comprehensive loss	(54,814)			(54,814)
Net income	207,761				207,761
Ending balance (in shares) at Oct. 31, 2022		292,319,353
Ending balance at Oct. 31, 2022	5,755,812	$ 292	3,572,368	(72,716)	2,255,868
Beginning balance (in shares) at Jul. 31, 2022		298,086,507
Beginning balance at Jul. 31, 2022	5,990,397	$ 298	3,830,745	(48,161)	2,207,515
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		229,183
Issuance of common stock upon exercise of stock options	1,809		1,809
Issuance of common stock upon release of restricted stock units (in shares)		959,192
Issuance of common stock upon release of restricted stock units	0	$ 1	(1)
Repurchase of common stock (in shares)		(6,955,529)
Repurchase of common stock	(564,832)	$ (7)	(564,825)
Stock-based compensation expense	304,640		304,640
Other comprehensive loss	(24,555)			(24,555)
Net income	48,353				48,353
Ending balance (in shares) at Oct. 31, 2022		292,319,353
Ending balance at Oct. 31, 2022	$ 5,755,812	$ 292	$ 3,572,368	$ (72,716)	$ 2,255,868

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities:
Net income	$ 207,761	$ 884,998
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	767,693	315,912
Amortization of deferred contract acquisition costs	186,626	125,691
Losses (gains) on strategic investments, net	78,014
(Losses) gains on strategic investments, net		(154,497)
Depreciation and amortization	57,921	35,275
Provision for accounts receivable allowances	39,580	23,482
Non-cash operating lease cost	16,949	13,131
Amortization of discount/premium on marketable securities	4,156	19,546
Other	41,928	2,127
Changes in operating assets and liabilities:
Accounts receivable	(238,020)	(108,541)
Prepaid expenses and other assets	(163,721)	(71,998)
Deferred contract acquisition costs	(217,822)	(165,305)
Accounts payable	24,561	12,062
Accrued expenses and other liabilities	116,391	171,914
Deferred revenue	174,325	304,513
Operating lease liabilities, net	(17,668)	(12,440)
Net cash provided by operating activities	1,078,674	1,395,870
Cash flows from investing activities:
Purchases of marketable securities	(1,927,049)	(3,446,313)
Maturities of marketable securities	2,137,875	1,047,545
Sales of marketable securities	0	281,582
Purchases of property and equipment	(75,568)	(111,816)
Purchases of strategic investments	(65,050)	(126,349)
Proceeds from strategic investments	300	0
Cash paid for acquisition, net of cash acquired	(120,553)	(2,121)
Purchases of intangible assets	(10,568)	(9,626)
Net cash used in investing activities	(60,613)	(2,367,098)
Cash flows from financing activities:
Cash paid for repurchases of common stock	(990,778)	0
Proceeds from issuance of common stock for employee stock purchase plan	34,605	37,846
Proceeds from employee equity transactions (remitted) to be remitted to employees and tax authorities, net	671	(28,342)
Proceeds from exercise of stock options	6,815	11,044
Other	0	337
Net cash (used in) provided by financing activities	(948,687)	20,885
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(36,639)	0
Net increase (decrease) in cash, cash equivalents, and restricted cash	32,735	(950,343)
Cash, cash equivalents, and restricted cash – beginning of period	1,073,353	2,293,116
Cash, cash equivalents, and restricted cash – end of period	1,106,088	1,342,773
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	1,096,174	1,322,435
Restricted cash, current included in prepaid expenses and other current assets	9,668	20,041
Restricted cash, noncurrent included in other assets, noncurrent	246	297
Total cash, cash equivalents, and restricted cash	$ 1,106,088	$ 1,342,773

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	9 Months Ended
Summary of Business and Significant Accounting Policies	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Description of Business Zoom Video Communications, Inc. and its subsidiaries (collectively, “Zoom,” the “Company,” “we,” “us,” or “our”) connect people through our core unified communications offering, which frictionlessly brings together video, phone, chat, webinars events, and contact center, and enables meaningful experiences across disparate devices and locations. We were incorporated in the state of Delaware in April 2011, and are headquartered in San Jose, California. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2023, for example, refer to the fiscal year ending January 31, 2023. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2022 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of operations, statements of comprehensive income, statements of stockholders’ equity, and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2022, filed with the SEC on March 7, 2022. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, stock-based compensation expense, sales and other tax liabilities, the fair value of marketable securities and strategic investments, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates. Summary of Significant Accounting Policies Our significant accounting policies are discussed in Note 1. “Summary of Business and Significant Accounting Policies” in the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2022, filed with the SEC on March 7, 2022. There have been no significant changes to these policies during the nine months ended October 31, 2022. Accounting Pronouncements Not Yet Adopted In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions , which clarifies and amends the guidance of measuring the fair value of equity securities subject to contractual restrictions that prohibit the sale of the equity securities. The guidance will be effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. We do not expect the adoption to have a material impact on our condensed consolidated financial statements.

Revenue Recognition

Revenue Recognition	9 Months Ended
Revenue Recognition	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following table summarizes revenue by region based on the billing address of customers: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Amount Percentage of Amount Percentage of Amount Percentage of Amount Percentage of (in thousands, except percentages) Americas $ 773,576 70 % $ 699,944 67 % $ 2,264,647 69 % $ 2,017,143 67 % Asia Pacific (“APAC”) 146,196 13 150,473 14 444,372 14 409,557 13 Europe, Middle East, and Africa (“EMEA”) 182,127 17 200,339 19 566,138 17 601,788 20 Total $ 1,101,899 100 % $ 1,050,756 100 % $ 3,275,157 100 % $ 3,028,488 100 % Contract Balances We receive payments from customers based on a billing schedule as established in our customer contracts. Accounts receivable are recorded when we contractually have the right to consideration. In some arrangements, a right to consideration for our performance under the customer contract may occur before invoicing to the customer, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net of allowances on the condensed consolidated balance sheets was $82.4 million and $59.7 million as of October 31, 2022 and January 31, 2022, respectively. Contract liabilities consist of deferred revenue. Revenue is deferred when we have the right to invoice in advance of performance under a customer contract. The current portion of deferred revenue balances is recognized over the next 12 months. The amount of revenue recognized during the three months ended October 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $586.1 million and $510.8 million, respectively, and $1,058.7 million and $802.0 million during the nine months ended October 31, 2022 and 2021, respectively. Remaining Performance Obligations The terms of our subscription agreements are monthly, annual, and multiyear, and we may bill for the full term in advance or on an annual, quarterly, or monthly basis, depending on the billing terms with customers. As of October 31, 2022, the aggregate amount of the transaction price allocated to our remaining performance obligations was $3,245.9 million, which consists of both billed consideration in the amount of $1,354.2 million and unbilled consideration in the amount of $1,891.7 million that we expect to recognize as revenue. We expect to recognize 59% of our remaining performance obligations as revenue over the next 12 months and the remainder thereafter.

Investments

Investments	9 Months Ended
Investments	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Marketable Securities As of October 31, 2022 and January 31, 2022, our marketable securities consisted of the following: As of October 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 40,432 $ — $ — $ 40,432 Agency bonds 643,133 — (16,989) 626,144 Corporate and other debt securities 394,948 — (7,686) 387,262 U.S. government agency securities 3,029,886 14 (71,343) 2,958,557 Treasury bills 56,554 — (131) 56,423 Marketable securities $ 4,164,953 $ 14 $ (96,149) $ 4,068,818 As of January 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 28,723 $ — $ — $ 28,723 Agency bonds 632,935 2 (3,328) 629,609 Corporate and other debt securities 282,124 5 (1,202) 280,927 U.S. government agency securities 3,046,742 28 (19,261) 3,027,509 Treasury bills 389,826 — (148) 389,678 Marketable securities $ 4,380,350 $ 35 $ (23,939) $ 4,356,446 Unrealized losses for securities that have been in an unrealized loss position for less than 12 months were $57.1 million as of October 31, 2022 and $23.3 million as of January 31, 2022. Unrealized losses for securities that have been in an unrealized loss position for 12 months or longer were $39.0 million as of October 31, 2022 and were immaterial as of January 31, 2022. We review the individual securities that have unrealized losses on a regular basis to evaluate whether or not any security has experienced, or is expected to experience, credit losses resulting in the decline in fair value. We evaluate, among other factors, whether we have the intention to sell any of these marketable securities and whether it is more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the high-grade credit rating for each of our marketable securities as of the end of each period. There were no material realized gains or losses from available-for-sale securities that were reclassified out of accumulated other comprehensive loss for the three and nine months ended October 31, 2022 and 2021. The following table presents the contractual maturities of our marketable securities as of October 31, 2022 and January 31, 2022: As of October 31, 2022 January 31, 2022 (in thousands) Less than one year $ 2,726,471 $ 2,387,139 Due in one to five years 1,342,347 1,969,307 Total $ 4,068,818 $ 4,356,446 Strategic Investments Strategic investments by form and measurement category as of October 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 132,405 $ 114,764 $ 93,096 $ 340,265 Debt securities 14,284 — — 14,284 Strategic investments $ 146,689 $ 114,764 $ 93,096 $ 354,549 Strategic investments by form and measurement category as of January 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 168,784 $ 91,399 $ 93,400 $ 353,583 Debt securities 14,231 — — 14,231 Strategic investments $ 183,015 $ 91,399 $ 93,400 $ 367,814 In the second quarter of fiscal year 2023, we made a strategic investment of $40.0 million for common shares in private placement by a company in the B2B software and services travel space. We recorded a loss of $17.8 million related to this investment for the nine months ended October 31, 2022. As of October 31, 2022, the fair value of the investment was $22.2 million and our ownership interest represents less than 1% percent of the economic interest of the investee's outstanding capital stock.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following tables present information about our financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: As of October 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 737,461 $ 737,461 $ — $ — Treasury bills 24,972 — 24,972 — Corporate debt securities 557 — 557 — Agency bonds 3,613 — 3,613 — Cash equivalents 766,603 737,461 29,142 — Commercial paper 40,432 — 40,432 — Agency bonds 626,144 — 626,144 — Corporate and other debt securities 387,262 — 387,262 — U.S. government agency securities 2,958,557 — 2,958,557 — Treasury bills 56,423 — 56,423 — Marketable securities 4,068,818 — 4,068,818 — Certificates of deposit included in other assets, noncurrent 246 — 246 — Publicly held equity securities included in strategic investments 132,405 132,405 — — Privately held debt securities included in strategic investments 14,284 — — 14,284 Total financial assets $ 4,982,356 $ 869,866 $ 4,098,206 $ 14,284 As of January 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 688,722 $ 688,722 $ — $ — Treasury bills 107,496 — 107,496 — Corporate debt securities 749 — 749 — Cash equivalents 796,967 688,722 108,245 — Commercial paper 28,723 — 28,723 — Agency bonds 629,609 — 629,609 — Corporate and other debt securities 280,927 — 280,927 — U.S. government agency securities 3,027,509 — 3,027,509 — Treasury bills 389,678 — 389,678 — Marketable securities 4,356,446 — 4,356,446 — Certificates of deposit included in other assets, noncurrent 297 — 297 — Publicly held equity securities included in strategic investments 168,784 168,784 — — Privately held debt securities included in strategic investments 14,231 — — 14,231 Total financial assets $ 5,336,725 $ 857,506 $ 4,464,988 $ 14,231 We classify our highly liquid money market funds and publicly held equity securities within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify our commercial paper, agency bonds, corporate and other debt securities, U.S. government agency securities, treasury bills, and certificates of deposit within Level 2 because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security, which may not be actively traded. We classify our privately held debt securities as Level 3 due to the lack of relevant observable market data over fair value inputs, such as the probability weighting of the various scenarios that can impact settlement of the arrangement.

Business Combinations

Business Combinations	9 Months Ended
Business Combinations	Oct. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations On May 19, 2022, we acquired 100% of the issued and outstanding share capital of Solvvy, Inc., a private technology company specializing in customer support automation, for an all-cash purchase consideration of $121.2 million. The acquisition adds to our customer service capabilities and enhances our integrated platform by providing conversational AI capabilities. The acquisition has been accounted for as a business combination. In allocating the purchase consideration, $94.9 million was attributed to goodwill, $26.7 million to intangible assets (consisted of $12.0 million to developed technology and $14.7 million to customer relationships), and $0.4 million to other net liabilities acquired. The goodwill amount represents synergies related to our existing products expected to be realized from the acquisition and assembled workforce. The associated goodwill is not deductible for tax purposes. At the date of the acquisition, the developed technology and customer relationships both had an estimated useful life of 5.0 years, and both are amortized using the straight-line method over their respective estimated useful lives. As of October 31, 2022, the developed technology and customer relationships both had a remaining useful life of 4.5 years. Transaction costs incurred in connection with the acquisition were immaterial. The results of operations of Solvvy, Inc., which are not material, have been included in our condensed consolidated financial statements from the date of the acquisition. Pro forma and historical results of operations of the company have not been presented, as the results do not have a material effect on any of the periods presented in our condensed consolidated statements of operations. Uncertain tax positions are initially established in connection with the acquisition as of the acquisition date. We continue to collect information and reevaluate these estimates and assumptions quarterly. We will record any adjustments to our preliminary estimates to goodwill, provided that it is within the one-year measurement period.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
Balance Sheet Components	Oct. 31, 2022
Balance Sheet Components [Abstract]
Balance Sheet Components	Balance Sheet Components Accounts Receivable, Net Accounts receivable are recorded for invoiced amounts and amounts for which revenue has been recognized, but not invoiced, net of allowances. Our short-term accounts receivable consist of the following: As of October 31, 2022 January 31, 2022 (in thousands) Accounts receivable, gross $ 624,606 $ 444,369 Less: allowance for credit losses (24,345) (17,000) Less: allowance for returns (10,688) (7,696) Accounts receivable, net $ 589,573 $ 419,673 Below is a rollforward of our allowance for credit losses for the nine months ended October 31, 2022 and 2021: 2022 2021 (in thousands) Balance as of January 31 $ 17,000 $ 20,500 Provision for credit losses 34,610 19,416 Write-offs (27,265) (18,816) Balance as of October 31 $ 24,345 $ 21,100 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Prepaid expenses $ 130,021 $ 112,666 Other receivables 17,657 20,423 Restricted cash from international employee stock sales 9,668 10,236 Other 8,315 2,277 Prepaid expenses and other current assets $ 165,661 $ 145,602 Property and Equipment, Net Property and equipment consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Servers $ 234,788 $ 185,491 Software 76,414 59,153 Computer and office equipment 47,199 39,410 Leasehold improvements 25,923 25,340 Furniture and fixtures 4,587 4,565 Property and equipment, gross 388,911 313,959 Less: accumulated depreciation and amortization (138,068) (91,605) Property and equipment, net $ 250,843 $ 222,354 Depreciation and amortization expense was $19.9 million and $12.4 million for the three months ended October 31, 2022 and 2021, respectively, and $54.6 million and $34.7 million for the nine months ended October 31, 2022 and 2021, respectively. Other Assets, Noncurrent Other assets, noncurrent consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Accounts receivable, noncurrent $ 71,399 $ 55,643 Intangible assets subject to amortization, net 33,420 2,972 Indefinite-lived intangible assets 25,254 21,020 Prepaid expenses, noncurrent 9,807 16,120 Other 12,428 11,006 Other assets, noncurrent $ 152,308 $ 106,761 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Accrued expenses $ 178,624 $ 149,658 Accrued compensation and benefits 165,794 126,322 Income tax liabilities 116,291 56,968 Sales and other non-income tax liabilities 31,057 33,305 Customer deposit liabilities 26,655 20,884 Operating lease liabilities, current 21,728 20,697 Other 21,151 22,581 Accrued expenses and other current liabilities $ 561,300 $ 430,415 Other Liabilities, Noncurrent Other liabilities, noncurrent consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Sales and other non-income tax liabilities $ 41,781 $ 53,916 Other 18,687 14,194 Other liabilities, noncurrent $ 60,468 $ 68,110

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations During the nine months ended October 31, 2022, there have been no material changes to our non-cancelable purchase obligations from those disclosed in Note 8. “Commitments and Contingencies” in the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2022, filed with the SEC on March 7, 2022. Other Contingencies In June 2020, we received a grand jury subpoena from the Department of Justice’s U.S. Attorney’s Office for Eastern District of New York (“EDNY”), which requested information regarding our interactions with foreign governments and foreign political parties, including the Chinese government, as well as information regarding storage of and access to user data, the development and implementation of Zoom’s privacy policies, and the actions we took relating to the Tiananmen commemorations on Zoom. In July 2020, we received subpoenas from the Department of Justice’s U.S. Attorney’s Office for the Northern District of California (“NDCA”) and the SEC. Both subpoenas seek documents and information relating to various security, data protection and privacy matters, including our encryption, and our statements relating thereto, as well as calculation of usage metrics and related public statements. In addition, the NDCA subpoena seeks information relating to any contacts between our employees and representatives of the Chinese government, and any attempted or successful influence by any foreign government in our policies, procedures, practices, and actions as they relate to users in the United States. We have since received additional subpoenas from EDNY and NDCA seeking related information. We are fully cooperating with all of these investigations and have been conducting our own thorough internal investigation. These investigations are ongoing, and we do not know when they will be completed, which facts we will ultimately discover as a result of the investigations, or what actions the government may or may not take. We cannot predict the outcome of these investigations, and a negative outcome in any or all of these matters could cause us to incur substantial fines, penalties, or other financial exposure, as well as reputational harm. Legal Proceedings On April 7, 2020 and April 8, 2020, securities class action complaints were filed against us and two of our officers in the United States District Court for the NDCA. The plaintiffs are purported stockholders of ours. The complaints allege, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 by making false and misleading statements and omissions of material fact about our data privacy and security measures. The complaints seek unspecified damages, interest, fees, and costs. On May 18, 2020, the actions were consolidated. On November 4, 2020, the court appointed a lead plaintiff. On December 23, 2020, the lead plaintiff filed a consolidated complaint. We filed a motion to dismiss the consolidated complaint on May 20, 2021. Plaintiff filed an opposition to our motion to dismiss on July 9, 2021. Our reply in support of the motion to dismiss was filed on August 9, 2021. On February 16, 2022, the court granted in part, and denied in part, our motion to dismiss. On March 14, 2022, we moved for reconsideration of the court’s ruling on the motion to dismiss. On March 22, 2022, the court ordered plaintiff to respond to our motion, which plaintiff did on March 29, 2022. On April 22, 2022, we answered the complaint. On June 11, 2020 and July 30, 2020, purported shareholder derivative complaints were filed in the United States District Court for the District of Delaware. The first complaint names as defendants nine of our officers and directors, and the second complaint names eight of our officers and directors. The lawsuits assert state and federal claims and are based on the same alleged misstatements as the shareholder class action complaint. The lawsuits accuse our board of directors of failing to exercise reasonable and prudent supervision over our management, policies, practices, and internal controls. The plaintiffs seek unspecified monetary damages on behalf of us as well as governance reforms. On September 25, 2020, the derivative cases were consolidated. The consolidated case is stayed pending resolution of the motion to dismiss the securities class action. On October 27, 2021, a third substantially identical lawsuit was filed in the same court against the same defendants, seeking unspecified monetary damages and governance reforms. On November 17, 2021, all three derivative lawsuits were consolidated and remain stayed pending resolution of the motion to dismiss the securities class action. We believe these lawsuits are without merit, and we are vigorously defending ourselves against them. Given the uncertainty of litigation, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, we cannot estimate the reasonably possible loss or range of loss that may result from these actions. Beginning on March 30, 2020, multiple putative class actions were filed against us in various U.S. federal district courts and state courts relating to our alleged privacy and security practices, including alleged data sharing with third parties (the “U.S. Privacy Class Actions”). The plaintiffs claim violations of a variety of state consumer protection and privacy laws, and also assert state constitutional and common law claims, such as negligence and unjust enrichment. The U.S. Privacy Class Actions seek to certify both nationwide and state-specific classes of individuals using our services in certain time periods. The plaintiffs seek various forms of injunctive and monetary relief, including restitution, statutory and actual damages, punitive damages, and attorneys’ fees. The federal cases have been transferred to and consolidated in the NDCA with our consent; lead plaintiffs’ counsel have been appointed; and plaintiffs filed their first amended consolidated class action complaint on October 28, 2020. On March 11, 2021, the court granted in part, and denied in part, our motion to dismiss, and gave plaintiffs leave to amend. On July 30, 2021, we entered into a settlement agreement with plaintiffs to settle the action on a classwide basis, and plaintiffs filed a motion for preliminary approval of the settlement with the court on July 31, 2021. On October 21, 2021, the Court preliminarily approved the settlement. Under the terms of the settlement, we have paid $85.0 million into an escrow account

Stockholders_ Equity and Equity

Stockholders’ Equity and Equity Incentive Plans	9 Months Ended
Stockholders’ Equity and Equity Incentive Plans	Oct. 31, 2022
Stockholders' Equity Note [Abstract]
Stockholders’ Equity and Equity Incentive Plans	Stockholders’ Equity and Equity Incentive Plans Common Stock Our amended and restated certificate of incorporation authorizes the issuance of 2,000,000,000 shares of Class A common stock, $0.001 par value per share, and 300,000,000 shares of Class B common stock, $0.001 par value per share. Class A and Class B common stock are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. Stock Repurchase Plan In February 2022, our Board of Directors authorized a stock repurchase program of up to $1.0 billion of our Class A common stock, which expires in February 2024. Repurchases of our Class A common stock may be effected from time to time, either on the open market (including preset trading plans), in privately negotiated transactions, and other transactions in accordance with applicable securities laws. The program does not obligate us to repurchase any specific number of shares and may be discontinued at any time. During the three and nine months ended October 31, 2022 , we repurchased and subsequently retired 6,955,529 and 11,044,500 shares of our Class A common stock, respectively, for an aggregate amount of $564.8 million and $990.8 million , respectively. As of October 31, 2022 , $9.2 million of the repurchase authorization remained available. Equity Incentive Plans We have two equity incentive plans: the 2011 Global Share Plan (“2011 Plan”) and the 2019 Equity Incentive Plan (“2019 Plan”). All shares that remain available for future grants are under the 2019 Plan. Stock Options A summary of stock option activity under our equity incentive plan and related information is as follows: Stock Options Outstanding Weighted- Weighted- Aggregate (in thousands, except share, life, and per share data) Balance as of January 31, 2022 6,195,205 $ 8.08 6.0 $ 905,744 Exercised (1,087,238) $ 6.27 $ 108,464 Canceled/forfeited/expired (88,836) $ 21.49 Outstanding as of October 31, 2022 5,019,131 $ 8.23 5.2 $ 378,841 Vested and expected to vest as of October 31, 2022 5,019,131 $ 8.23 5.2 $ 378,841 Exercisable as of October 31, 2022 4,861,214 $ 7.28 5.1 $ 371,257 As of October 31, 2022, unrecognized stock-based compensation expense related to outstanding unvested stock options was $3.5 million, which is expected to be recognized over a weighted-average period of 0.4 years. Restricted Stock Units A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows: RSUs RSUs Weighted- Unvested as of January 31, 2022 5,546,366 $ 232.58 Granted 17,750,637 $ 98.47 Vested (2,865,551) $ 186.03 Canceled/forfeited (1,392,277) $ 159.55 Unvested as of October 31, 2022 19,039,175 $ 119.88 In March and October 2022, changes made to our equity compensation program resulted in modifications of the value of RSUs offered to our employees. This activity has been included in our total Stock-Based Compensation disclosures below. As of October 31, 2022, unrecognized stock-based compensation expense related to RSUs was $2,899.4 million, including the impact of the modification, which is expected to be recognized over a weighted-average period of 2.8 years. 2019 Employee Stock Purchase Plan In April 2019, we adopted the 2019 Employee Stock Purchase Plan (“ESPP”). As of October 31, 2022, unrecognized stock-based compensation expense related to the ESPP was $66.5 million, which is expected to be recognized over a weighted-average period of 1.3 years. Stock-Based Compensation The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 (in thousands) Cost of revenue $ 41,449 $ 17,206 $ 109,776 $ 46,050 Research and development 83,202 27,879 208,654 71,615 Sales and marketing 125,144 54,220 329,100 156,888 General and administrative 53,020 15,496 120,163 41,359 Total stock-based compensation expense $ 302,815 $ 114,801 $ 767,693 $ 315,912 Benefit from income taxes (53,995) — (151,027) — Total stock-based compensation expense recorded to net income $ 248,820 $ 114,801 $ 616,666 $ 315,912

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date ordinary income and adjust the provision for discrete tax items recorded in the period. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. The following table provides details of the provision for income taxes: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 (in thousands, except percentages) Income before provision for income taxes $ 54,749 $ 410,283 $ 288,820 $ 963,098 Provision for income taxes 6,396 69,900 81,059 78,100 Effective tax rate 11.7 % 17.0 % 28.1 % 8.1 % We had a provision for income taxes of $6.4 million and $69.9 million for the three months ended October 31, 2022 and 2021, respectively. The provision for income taxes was $81.1 million and $78.1 million for the nine months ended October 31, 2022 and 2021, respectively. The year-over-year change in effective tax rate for the three and nine months ended October 31, 2022 was due primarily to changes in the valuation allowance, tax shortfalls and windfalls on stock-based compensation, and the foreign-derived intangible income deduction. For the three and nine months ended October 31, 2022, the effective tax rate differed from the U.S. federal statutory rate due primarily to the foreign-derived intangible income deduction and research credits, offset by tax shortfalls on stock-based compensation, the valuation allowance recorded on the deferred tax asset related to losses that are capital in nature, and other compensation-related permanent differences. For the three and nine months ended October 31, 2021, the effective tax rate differed from the U.S. federal statutory rate due primarily to tax windfalls on stock-based compensation, research credits, and the foreign-derived intangible income deduction in addition to a full valuation allowance on the U.S. deferred tax assets that was released in the fourth quarter of fiscal year 2022. The realization of tax benefits of net deferred tax assets is dependent upon future levels of taxable income, of an appropriate character, in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the three and nine months ended October 31, 2022, we continue to believe that it is more likely than not that the tax benefits of the U.K. net deferred tax assets may not be realized. Accordingly, we maintained a full valuation allowance against the tax benefits of these net deferred tax assets. Based on the available objective evidence during the three and nine months ended October 31, 2022, we believe that it is more likely than not that the tax benefits relating to U.S. losses that are capital in nature may not be realized prior to expiration. Accordingly, we have maintained a valuation allowance against these deferred tax assets. We intend to maintain the applicable valuation allowance until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. During the three and nine months ended October 31, 2022, there were no material changes to the total amount of unrecognized tax benefits and we do not expect any significant changes in the next 12 months. As required by the 2017 Tax Cuts and Jobs Act, we are capitalizing research and development expenses incurred in fiscal year 2023. These expenses are capitalized and amortized over five years for domestic research and fifteen years for international research. The mandatory capitalization requirement increases our cash tax liabilities but also decreases our effective tax rate due to increasing the foreign-derived intangible income deduction. The cash flow impact will decrease over time as capitalized research and development expenditures continue to amortize. The Inflation Reduction Act was signed into law in August 2022. The act included tax provisions for a 15% corporate book income minimum tax effective for tax years beginning after December 31, 2022. We do not expect the Inflation Reduction Act to have a material impact on our condensed consolidated financial statements.

Net Income Per Share Attributab

Net Income Per Share Attributable to Common Stockholders	9 Months Ended
Net Income Per Share Attributable to Common Stockholders	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Income Per Share Attributable to Common Stockholders	Net Income Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B (in thousands, except share and per share data) Numerator: Net income $ 40,726 $ 7,627 $ 276,024 $ 64,359 $ 174,835 $ 32,926 $ 707,188 $ 177,810 Less: undistributed earnings attributable to participating securities — — — (112) — (17) — (430) Net income attributable to common stockholders, basic $ 40,726 $ 7,627 $ 276,024 $ 64,247 $ 174,835 $ 32,909 $ 707,188 $ 177,380 Reallocation of net income attributable to common stockholders (568) 568 (5,756) 5,756 (2,516) 2,516 (15,965) 15,965 Net income attributable to common stockholders, diluted $ 40,158 $ 8,195 $ 270,268 $ 70,003 $ 172,319 $ 35,425 $ 691,223 $ 193,345 Denominator: Weighted-average shares used in computing net income per share attributable to common stockholders, basic 248,917,590 46,619,436 241,227,457 56,147,554 250,595,877 47,169,971 236,362,585 59,285,041 Weighted-average shares used in computing net income per share attributable to common stockholders, diluted 250,803,759 51,182,582 243,024,399 62,915,225 253,217,436 52,056,376 238,904,473 66,822,260 Net income per share attributable to common stockholders, basic $ 0.16 $ 0.16 $ 1.14 $ 1.14 $ 0.70 $ 0.70 $ 2.99 $ 2.99 Net income per share attributable to common stockholders, diluted $ 0.16 $ 0.16 $ 1.11 $ 1.11 $ 0.68 $ 0.68 $ 2.89 $ 2.89 The potential shares of common stock that were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive, are as follows: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Unvested RSUs 12,741,748 — 816,953 — 7,656,321 — 473,104 — Purchase rights committed under the ESPP 2,395,761 — 584,212 — 1,462,148 — 284,454 — Outstanding stock options 124,547 — — — 75,984 — — — Total 15,262,056 — 1,401,165 — 9,194,453 — 757,558 — The table above does not include 405,156 shares of issued Class A common stock held by us as of October 31, 2022 and 2021 that are reserved for the sole purpose of being transferred to nonprofit organizations.

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, stock-based compensation expense, sales and other tax liabilities, the fair value of marketable securities and strategic investments, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates.
Accounting Pronouncements Not Yet Adopted	Accounting Pronouncements Not Yet Adopted In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions , which clarifies and amends the guidance of measuring the fair value of equity securities subject to contractual restrictions that prohibit the sale of the equity securities. The guidance will be effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. We do not expect the adoption to have a material impact on our condensed consolidated financial statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
Revenue Recognition (Tables)	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Region	The following table summarizes revenue by region based on the billing address of customers: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Amount Percentage of Amount Percentage of Amount Percentage of Amount Percentage of (in thousands, except percentages) Americas $ 773,576 70 % $ 699,944 67 % $ 2,264,647 69 % $ 2,017,143 67 % Asia Pacific (“APAC”) 146,196 13 150,473 14 444,372 14 409,557 13 Europe, Middle East, and Africa (“EMEA”) 182,127 17 200,339 19 566,138 17 601,788 20 Total $ 1,101,899 100 % $ 1,050,756 100 % $ 3,275,157 100 % $ 3,028,488 100 %

Investments (Tables)

Investments (Tables)	9 Months Ended
Investments (Tables)	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	As of October 31, 2022 and January 31, 2022, our marketable securities consisted of the following: As of October 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 40,432 $ — $ — $ 40,432 Agency bonds 643,133 — (16,989) 626,144 Corporate and other debt securities 394,948 — (7,686) 387,262 U.S. government agency securities 3,029,886 14 (71,343) 2,958,557 Treasury bills 56,554 — (131) 56,423 Marketable securities $ 4,164,953 $ 14 $ (96,149) $ 4,068,818 As of January 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 28,723 $ — $ — $ 28,723 Agency bonds 632,935 2 (3,328) 629,609 Corporate and other debt securities 282,124 5 (1,202) 280,927 U.S. government agency securities 3,046,742 28 (19,261) 3,027,509 Treasury bills 389,826 — (148) 389,678 Marketable securities $ 4,380,350 $ 35 $ (23,939) $ 4,356,446
Schedule of Contractual Maturities of Marketable Securities	The following table presents the contractual maturities of our marketable securities as of October 31, 2022 and January 31, 2022: As of October 31, 2022 January 31, 2022 (in thousands) Less than one year $ 2,726,471 $ 2,387,139 Due in one to five years 1,342,347 1,969,307 Total $ 4,068,818 $ 4,356,446
Schedule of Strategic Investments	Strategic investments by form and measurement category as of October 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 132,405 $ 114,764 $ 93,096 $ 340,265 Debt securities 14,284 — — 14,284 Strategic investments $ 146,689 $ 114,764 $ 93,096 $ 354,549 Strategic investments by form and measurement category as of January 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 168,784 $ 91,399 $ 93,400 $ 353,583 Debt securities 14,231 — — 14,231 Strategic investments $ 183,015 $ 91,399 $ 93,400 $ 367,814

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis	The following tables present information about our financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: As of October 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 737,461 $ 737,461 $ — $ — Treasury bills 24,972 — 24,972 — Corporate debt securities 557 — 557 — Agency bonds 3,613 — 3,613 — Cash equivalents 766,603 737,461 29,142 — Commercial paper 40,432 — 40,432 — Agency bonds 626,144 — 626,144 — Corporate and other debt securities 387,262 — 387,262 — U.S. government agency securities 2,958,557 — 2,958,557 — Treasury bills 56,423 — 56,423 — Marketable securities 4,068,818 — 4,068,818 — Certificates of deposit included in other assets, noncurrent 246 — 246 — Publicly held equity securities included in strategic investments 132,405 132,405 — — Privately held debt securities included in strategic investments 14,284 — — 14,284 Total financial assets $ 4,982,356 $ 869,866 $ 4,098,206 $ 14,284 As of January 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 688,722 $ 688,722 $ — $ — Treasury bills 107,496 — 107,496 — Corporate debt securities 749 — 749 — Cash equivalents 796,967 688,722 108,245 — Commercial paper 28,723 — 28,723 — Agency bonds 629,609 — 629,609 — Corporate and other debt securities 280,927 — 280,927 — U.S. government agency securities 3,027,509 — 3,027,509 — Treasury bills 389,678 — 389,678 — Marketable securities 4,356,446 — 4,356,446 — Certificates of deposit included in other assets, noncurrent 297 — 297 — Publicly held equity securities included in strategic investments 168,784 168,784 — — Privately held debt securities included in strategic investments 14,231 — — 14,231 Total financial assets $ 5,336,725 $ 857,506 $ 4,464,988 $ 14,231

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
Balance Sheet Components (Tables)	Oct. 31, 2022
Balance Sheet Components [Abstract]
Schedule of Accounts Receivable	Our short-term accounts receivable consist of the following: As of October 31, 2022 January 31, 2022 (in thousands) Accounts receivable, gross $ 624,606 $ 444,369 Less: allowance for credit losses (24,345) (17,000) Less: allowance for returns (10,688) (7,696) Accounts receivable, net $ 589,573 $ 419,673
Schedule of Accounts Receivable, Allowance for Credit Loss	Below is a rollforward of our allowance for credit losses for the nine months ended October 31, 2022 and 2021: 2022 2021 (in thousands) Balance as of January 31 $ 17,000 $ 20,500 Provision for credit losses 34,610 19,416 Write-offs (27,265) (18,816) Balance as of October 31 $ 24,345 $ 21,100
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Prepaid expenses $ 130,021 $ 112,666 Other receivables 17,657 20,423 Restricted cash from international employee stock sales 9,668 10,236 Other 8,315 2,277 Prepaid expenses and other current assets $ 165,661 $ 145,602
Schedule of Property and Equipment	Property and equipment consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Servers $ 234,788 $ 185,491 Software 76,414 59,153 Computer and office equipment 47,199 39,410 Leasehold improvements 25,923 25,340 Furniture and fixtures 4,587 4,565 Property and equipment, gross 388,911 313,959 Less: accumulated depreciation and amortization (138,068) (91,605) Property and equipment, net $ 250,843 $ 222,354
Schedule of Other Noncurrent Assets	Other assets, noncurrent consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Accounts receivable, noncurrent $ 71,399 $ 55,643 Intangible assets subject to amortization, net 33,420 2,972 Indefinite-lived intangible assets 25,254 21,020 Prepaid expenses, noncurrent 9,807 16,120 Other 12,428 11,006 Other assets, noncurrent $ 152,308 $ 106,761
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Accrued expenses $ 178,624 $ 149,658 Accrued compensation and benefits 165,794 126,322 Income tax liabilities 116,291 56,968 Sales and other non-income tax liabilities 31,057 33,305 Customer deposit liabilities 26,655 20,884 Operating lease liabilities, current 21,728 20,697 Other 21,151 22,581 Accrued expenses and other current liabilities $ 561,300 $ 430,415
Schedule of Other Liabilities Non Current	Other liabilities, noncurrent consisted of the following: As of October 31, 2022 January 31, 2022 (in thousands) Sales and other non-income tax liabilities $ 41,781 $ 53,916 Other 18,687 14,194 Other liabilities, noncurrent $ 60,468 $ 68,110

Stockholders_ Equity and Equi_2

Stockholders’ Equity and Equity Incentive Plans (Tables)	9 Months Ended
Stockholders’ Equity and Equity Incentive Plans (Tables)	Oct. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of Stock Option Activity Under Equity Incentive Plan	A summary of stock option activity under our equity incentive plan and related information is as follows: Stock Options Outstanding Weighted- Weighted- Aggregate (in thousands, except share, life, and per share data) Balance as of January 31, 2022 6,195,205 $ 8.08 6.0 $ 905,744 Exercised (1,087,238) $ 6.27 $ 108,464 Canceled/forfeited/expired (88,836) $ 21.49 Outstanding as of October 31, 2022 5,019,131 $ 8.23 5.2 $ 378,841 Vested and expected to vest as of October 31, 2022 5,019,131 $ 8.23 5.2 $ 378,841 Exercisable as of October 31, 2022 4,861,214 $ 7.28 5.1 $ 371,257
Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan	A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows: RSUs RSUs Weighted- Unvested as of January 31, 2022 5,546,366 $ 232.58 Granted 17,750,637 $ 98.47 Vested (2,865,551) $ 186.03 Canceled/forfeited (1,392,277) $ 159.55 Unvested as of October 31, 2022 19,039,175 $ 119.88
Schedule of Stock-based Compensation Expense by Line Item	The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 (in thousands) Cost of revenue $ 41,449 $ 17,206 $ 109,776 $ 46,050 Research and development 83,202 27,879 208,654 71,615 Sales and marketing 125,144 54,220 329,100 156,888 General and administrative 53,020 15,496 120,163 41,359 Total stock-based compensation expense $ 302,815 $ 114,801 $ 767,693 $ 315,912 Benefit from income taxes (53,995) — (151,027) — Total stock-based compensation expense recorded to net income $ 248,820 $ 114,801 $ 616,666 $ 315,912

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
Income Taxes (Tables)	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes	The following table provides details of the provision for income taxes: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 (in thousands, except percentages) Income before provision for income taxes $ 54,749 $ 410,283 $ 288,820 $ 963,098 Provision for income taxes 6,396 69,900 81,059 78,100 Effective tax rate 11.7 % 17.0 % 28.1 % 8.1 %

Net Income Per Share Attribut_2

Net Income Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Income Per Share	The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B (in thousands, except share and per share data) Numerator: Net income $ 40,726 $ 7,627 $ 276,024 $ 64,359 $ 174,835 $ 32,926 $ 707,188 $ 177,810 Less: undistributed earnings attributable to participating securities — — — (112) — (17) — (430) Net income attributable to common stockholders, basic $ 40,726 $ 7,627 $ 276,024 $ 64,247 $ 174,835 $ 32,909 $ 707,188 $ 177,380 Reallocation of net income attributable to common stockholders (568) 568 (5,756) 5,756 (2,516) 2,516 (15,965) 15,965 Net income attributable to common stockholders, diluted $ 40,158 $ 8,195 $ 270,268 $ 70,003 $ 172,319 $ 35,425 $ 691,223 $ 193,345 Denominator: Weighted-average shares used in computing net income per share attributable to common stockholders, basic 248,917,590 46,619,436 241,227,457 56,147,554 250,595,877 47,169,971 236,362,585 59,285,041 Weighted-average shares used in computing net income per share attributable to common stockholders, diluted 250,803,759 51,182,582 243,024,399 62,915,225 253,217,436 52,056,376 238,904,473 66,822,260 Net income per share attributable to common stockholders, basic $ 0.16 $ 0.16 $ 1.14 $ 1.14 $ 0.70 $ 0.70 $ 2.99 $ 2.99 Net income per share attributable to common stockholders, diluted $ 0.16 $ 0.16 $ 1.11 $ 1.11 $ 0.68 $ 0.68 $ 2.89 $ 2.89
Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders	The potential shares of common stock that were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive, are as follows: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Unvested RSUs 12,741,748 — 816,953 — 7,656,321 — 473,104 — Purchase rights committed under the ESPP 2,395,761 — 584,212 — 1,462,148 — 284,454 — Outstanding stock options 124,547 — — — 75,984 — — — Total 15,262,056 — 1,401,165 — 9,194,453 — 757,558 —

Revenue Recognition - Summary D

Revenue Recognition - Summary Disaggregation of Revenue by Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 1,101,899	$ 1,050,756	$ 3,275,157	$ 3,028,488
Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	100%	100%	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Revenue	$ 773,576	$ 699,944	$ 2,264,647	$ 2,017,143
Americas \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	70%	67%	69%	67%
Asia Pacific (“APAC”)
Disaggregation of Revenue [Line Items]
Revenue	$ 146,196	$ 150,473	$ 444,372	$ 409,557
Asia Pacific (“APAC”) \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	13%	14%	14%	13%
Europe, Middle East, and Africa (“EMEA”)
Disaggregation of Revenue [Line Items]
Revenue	$ 182,127	$ 200,339	$ 566,138	$ 601,788
Europe, Middle East, and Africa (“EMEA”) \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	17%	19%	17%	20%

Revenue Recognition - Contract

Revenue Recognition - Contract Balances (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Unbilled contracts receivable	$ 82.4		$ 82.4		$ 59.7
Revenue recognized included in deferred revenue	$ 586.1	$ 510.8	$ 1,058.7	$ 802

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligation (Details) $ in Millions	Oct. 31, 2022 USD ($)
Disaggregation of Revenue [Line Items]
Remaining Performance Obligation	$ 3,245.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as a percent)	59%
Revenue remaining performance obligation, expected timing of satisfaction period (in months)	12 months
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining Performance Obligation	$ 1,354.2
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining Performance Obligation	$ 1,891.7

Investments - Summary of Market

Investments - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Marketable Securities [Line Items]
Amortized Cost	$ 4,164,953	$ 4,380,350
Gross Unrealized Gains	14	35
Gross Unrealized Losses	(96,149)	(23,939)
Estimated Fair Value	4,068,818	4,356,446
Commercial paper
Marketable Securities [Line Items]
Amortized Cost	40,432	28,723
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	40,432	28,723
Agency bonds
Marketable Securities [Line Items]
Amortized Cost	643,133	632,935
Gross Unrealized Gains	0	2
Gross Unrealized Losses	(16,989)	(3,328)
Estimated Fair Value	626,144	629,609
Corporate and other debt securities
Marketable Securities [Line Items]
Amortized Cost	394,948	282,124
Gross Unrealized Gains	0	5
Gross Unrealized Losses	(7,686)	(1,202)
Estimated Fair Value	387,262	280,927
U.S. government agency securities
Marketable Securities [Line Items]
Amortized Cost	3,029,886	3,046,742
Gross Unrealized Gains	14	28
Gross Unrealized Losses	(71,343)	(19,261)
Estimated Fair Value	2,958,557	3,027,509
Treasury bills
Marketable Securities [Line Items]
Amortized Cost	56,554	389,826
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(131)	(148)
Estimated Fair Value	$ 56,423	$ 389,678

Investments - Additional Inform

Investments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jul. 31, 2022	Oct. 31, 2022	Jan. 31, 2022
Fair Value, Separate Account Investment [Line Items]
Unrealized losses for securities in unrealized loss position for less than 12 months		$ 57,100	$ 23,300
Unrealized losses for securities in unrealized loss position for 12 months or longer		39,000	0
Fair Value
Fair Value, Separate Account Investment [Line Items]
Equity securities		132,405	$ 168,784
Strategic Investment Of Technology Company
Fair Value, Separate Account Investment [Line Items]
Purchase of strategic investments	$ 40,000
Unrealized loss on securities		(17,800)
Strategic Investment Of Technology Company \| Fair Value
Fair Value, Separate Account Investment [Line Items]
Equity securities		$ 22,200
Ownership percentage (less than) (as a percent)		1%

Investments - Summary of Contra

Investments - Summary of Contractual Maturities of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Less than one year	$ 2,726,471	$ 2,387,139
Due in one to five years	1,342,347	1,969,307
Total	$ 4,068,818	$ 4,356,446

Investments - Schedule of Strat

Investments - Schedule of Strategic Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement Alternative	$ 114,764	$ 91,399
Equity Method	93,096	93,400
Total equity securities	340,265	353,583
Debt securities	14,284	14,231
Fair value of strategic investments	146,689	183,015
Total strategic investments	354,549	367,814
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities	132,405	168,784
Debt securities	$ 14,284	$ 14,231

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Financial Assets:
Marketable securities	$ 4,068,818	$ 4,356,446
Commercial paper
Financial Assets:
Marketable securities	40,432	28,723
Agency bonds
Financial Assets:
Marketable securities	626,144	629,609
Corporate and other debt securities
Financial Assets:
Marketable securities	387,262	280,927
U.S. government agency securities
Financial Assets:
Marketable securities	2,958,557	3,027,509
Fair Value, Recurring Basis
Financial Assets:
Cash equivalents	766,603	796,967
Marketable securities	4,068,818	4,356,446
Publicly held equity securities included in strategic investments	132,405	168,784
Total financial assets	4,982,356	5,336,725
Fair Value, Recurring Basis \| Commercial paper
Financial Assets:
Marketable securities	40,432	28,723
Fair Value, Recurring Basis \| Agency bonds
Financial Assets:
Marketable securities	626,144	629,609
Fair Value, Recurring Basis \| Corporate and other debt securities
Financial Assets:
Marketable securities	387,262	280,927
Fair Value, Recurring Basis \| U.S. government agency securities
Financial Assets:
Marketable securities	2,958,557	3,027,509
Fair Value, Recurring Basis \| Treasury bills
Financial Assets:
Marketable securities	56,423	389,678
Fair Value, Recurring Basis \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	246	297
Fair Value, Recurring Basis \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	14,284	14,231
Fair Value, Recurring Basis \| Money market funds
Financial Assets:
Cash equivalents	737,461	688,722
Fair Value, Recurring Basis \| Treasury bills
Financial Assets:
Cash equivalents	24,972	107,496
Fair Value, Recurring Basis \| Corporate debt securities
Financial Assets:
Cash equivalents	557	749
Fair Value, Recurring Basis \| Agency bonds
Financial Assets:
Cash equivalents	3,613
Fair Value, Recurring Basis \| Level 1
Financial Assets:
Cash equivalents	737,461	688,722
Marketable securities	0	0
Publicly held equity securities included in strategic investments	132,405	168,784
Total financial assets	869,866	857,506
Fair Value, Recurring Basis \| Level 1 \| Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis \| Level 1 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Money market funds
Financial Assets:
Cash equivalents	737,461	688,722
Fair Value, Recurring Basis \| Level 1 \| Treasury bills
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis \| Level 1 \| Corporate debt securities
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis \| Level 1 \| Agency bonds
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis \| Level 2
Financial Assets:
Cash equivalents	29,142	108,245
Marketable securities	4,068,818	4,356,446
Publicly held equity securities included in strategic investments	0	0
Total financial assets	4,098,206	4,464,988
Fair Value, Recurring Basis \| Level 2 \| Commercial paper
Financial Assets:
Marketable securities	40,432	28,723
Fair Value, Recurring Basis \| Level 2 \| Agency bonds
Financial Assets:
Marketable securities	626,144	629,609
Fair Value, Recurring Basis \| Level 2 \| Corporate and other debt securities
Financial Assets:
Marketable securities	387,262	280,927
Fair Value, Recurring Basis \| Level 2 \| U.S. government agency securities
Financial Assets:
Marketable securities	2,958,557	3,027,509
Fair Value, Recurring Basis \| Level 2 \| Treasury bills
Financial Assets:
Marketable securities	56,423	389,678
Fair Value, Recurring Basis \| Level 2 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	246	297
Fair Value, Recurring Basis \| Level 2 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 2 \| Money market funds
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis \| Level 2 \| Treasury bills
Financial Assets:
Cash equivalents	24,972	107,496
Fair Value, Recurring Basis \| Level 2 \| Corporate debt securities
Financial Assets:
Cash equivalents	557	749
Fair Value, Recurring Basis \| Level 2 \| Agency bonds
Financial Assets:
Cash equivalents	3,613
Fair Value, Recurring Basis \| Level 3
Financial Assets:
Cash equivalents	0	0
Marketable securities	0	0
Publicly held equity securities included in strategic investments	0	0
Total financial assets	14,284	14,231
Fair Value, Recurring Basis \| Level 3 \| Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis \| Level 3 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	14,284	14,231
Fair Value, Recurring Basis \| Level 3 \| Money market funds
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis \| Level 3 \| Treasury bills
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis \| Level 3 \| Corporate debt securities
Financial Assets:
Cash equivalents	0	$ 0
Fair Value, Recurring Basis \| Level 3 \| Agency bonds
Financial Assets:
Cash equivalents	$ 0

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands		9 Months Ended
Business Combinations (Details) - USD ($) $ in Thousands	May 19, 2022	Oct. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 122,556	$ 27,607
Solvvy, Inc.
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired (as a percent)	100%
Cash consideration paid	$ 121,200
Goodwill	94,900
Intangible assets, other than goodwill	26,700
Other net liabilities acquired	(400)
Solvvy, Inc. \| Developed Technology Rights
Business Acquisition [Line Items]
Intangible assets, other than goodwill	$ 12,000
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years	4 years 6 months
Solvvy, Inc. \| Customer Relationships
Business Acquisition [Line Items]
Intangible assets, other than goodwill	$ 14,700
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years	4 years 6 months

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2021
Property, Plant and Equipment [Abstract]
Accounts receivable, gross	$ 624,606	$ 444,369
Less: allowance for credit losses	(24,345)	(17,000)	$ (21,100)	$ (20,500)
Less: allowance for returns	(10,688)	(7,696)
Accounts receivable, net	$ 589,573	$ 419,673

Balance Sheet Components - Roll

Balance Sheet Components - Rollforward of Allowance For Credit Losses (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 17,000	$ 20,500
Provision for credit losses	34,610	19,416
Write-offs	(27,265)	(18,816)
Ending balance	$ 24,345	$ 21,100

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Prepaid expenses	$ 130,021	$ 112,666
Other receivables	17,657	20,423
Restricted cash from international employee stock sales	9,668	10,236
Other	8,315	2,277
Prepaid expenses and other current assets	$ 165,661	$ 145,602

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Property and Equipment Net (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 388,911	$ 313,959
Less: accumulated depreciation and amortization	(138,068)	(91,605)
Property and equipment, net	250,843	222,354
Servers
Property, Plant and Equipment [Line Items]
Property and equipment, gross	234,788	185,491
Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	76,414	59,153
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	47,199	39,410
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	25,923	25,340
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 4,587	$ 4,565

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Balance Sheet Components [Abstract]
Depreciation and amortization expense	$ 19.9	$ 12.4	$ 54.6	$ 34.7

Balance Sheet Components - Othe

Balance Sheet Components - Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Accounts receivable, noncurrent	$ 71,399	$ 55,643
Intangible assets subject to amortization, net	33,420	2,972
Indefinite-lived intangible assets	25,254	21,020
Prepaid expenses, noncurrent	9,807	16,120
Other	12,428	11,006
Other assets, noncurrent	$ 152,308	$ 106,761

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Accrued expenses	$ 178,624	$ 149,658
Accrued compensation and benefits	165,794	126,322
Income tax liabilities	116,291	56,968
Sales and other non-income tax liabilities	31,057	33,305
Customer deposit liabilities	26,655	20,884
Operating lease liabilities, current	21,728	20,697
Other	21,151	22,581
Accrued expenses and other current liabilities	$ 561,300	$ 430,415

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Other Liabilities Non Current (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Sales and other non-income tax liabilities	$ 41,781	$ 53,916
Other	18,687	14,194
Other liabilities, noncurrent	$ 60,468	$ 68,110

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Oct. 17, 2022 objector	May 19, 2022 objector	Oct. 21, 2021 USD ($)	Jul. 30, 2020 officer	Jun. 11, 2020 officer	Apr. 08, 2020 officer	Nov. 17, 2021 lawsuit
Other Commitments [Line Items]
Number of derivative lawsuits \| lawsuit							3
Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5
Other Commitments [Line Items]
Loss contingency, number of defendants \| officer				8	9	2
U.S. Privacy Class Actions
Other Commitments [Line Items]
Loss contingency, number of defendants \| objector	3	2
Payments for legal settlements \| $			$ 85

Stockholders_ Equity and Equi_3

Stockholders’ Equity and Equity Incentive Plans - Additional Information (Details)	3 Months Ended	9 Months Ended
	Oct. 31, 2022 USD ($) plan $ / shares shares	Oct. 31, 2022 USD ($) plan $ / shares shares	Feb. 28, 2022 USD ($)	Jan. 31, 2022 $ / shares shares	Apr. 30, 2019 $ / shares shares
Class of Stock [Line Items]
Common stock, par value (in dollars per share) \| $ / shares	$ 0.001	$ 0.001		$ 0.001
Stock repurchase plan, authorized amount (up to)			$ 1,000,000,000
Stock repurchased and retired during period (in shares) \| shares	6,955,529	11,044,500
Stock repurchased and retired during period	$ 564,800,000	$ 990,800,000
Remaining authorized amount	$ 9,200,000	$ 9,200,000
Number of equity incentive plans \| plan	2	2
Stock Options
Class of Stock [Line Items]
Unrecognized stock-based compensation expenses related to outstanding unvested stock options	$ 3,500,000	$ 3,500,000
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		4 months 24 days
RSUs
Class of Stock [Line Items]
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		2 years 9 months 18 days
Unrecognized stock-based compensation expenses	2,899,400,000	$ 2,899,400,000
Employee Stock Purchase Plan
Class of Stock [Line Items]
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		1 year 3 months 18 days
Unrecognized stock-based compensation expenses	$ 66,500,000	$ 66,500,000
Class A Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares	2,000,000,000	2,000,000,000		2,000,000,000
Class A Common Stock \| Initial Public Offering
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares					2,000,000,000
Common stock, par value (in dollars per share) \| $ / shares					$ 0.001
Class B Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares	300,000,000	300,000,000		300,000,000
Class B Common Stock \| Initial Public Offering
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares					300,000,000
Common stock, par value (in dollars per share) \| $ / shares					$ 0.001

Stockholders_ Equity and Equi_4

Stockholders’ Equity and Equity Incentive Plans - Summary of Stock Option Activity Under Equity Incentive Plan (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares
Outstanding Stock Options
Beginning balance (in shares) \| shares	6,195,205
Exercised (in shares) \| shares	(1,087,238)
Cancelled/forfeited/expired (in shares) \| shares	(88,836)
Ending balance (in shares) \| shares	5,019,131	6,195,205
Vested and expected to vest (in shares) \| shares	5,019,131
Exercisable (in shares) \| shares	4,861,214
Weighted- Average Exercise Price
Beginning balance (in dollars per share) \| $ / shares	$ 8.08
Exercised (in dollars per share) \| $ / shares	6.27
Cancelled/forfeited/expired (in dollars per share) \| $ / shares	21.49
Ending balance (in dollars per share) \| $ / shares	8.23	$ 8.08
Weighted average exercise price, vested and expected to vest (in dollars per share) \| $ / shares	8.23
Weighted average exercise price, exercisable (in dollars per share) \| $ / shares	$ 7.28
Weighted- Average Remaining Contractual Life (Years)
Outstanding (in years)	5 years 2 months 12 days	6 years
Vested and expected to vest (in years)	5 years 2 months 12 days
Weighted-average remaining contractual life, exercisable (in years)	5 years 1 month 6 days
Aggregate Intrinsic Value
Outstanding \| $	$ 378,841	$ 905,744
Exercised \| $	108,464
Vested and expected to vest \| $	378,841
Options outstanding, aggregate intrinsic value, exercisable \| $	$ 371,257

Stockholders_ Equity and Equi_5

Stockholders’ Equity and Equity Incentive Plans - Summary of Restricted Stock Units Activity Under Equity Incentive Plan (Details) - RSUs	9 Months Ended
	Oct. 31, 2022 $ / shares shares
RSUs
Beginning balance (in shares) \| shares	5,546,366
Granted (in shares) \| shares	17,750,637
Vested (in shares) \| shares	(2,865,551)
Cancelled/forfeited (in shares) \| shares	(1,392,277)
Ending balance (in shares) \| shares	19,039,175
Weighted- Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) \| $ / shares	$ 232.58
Granted (in dollars per share) \| $ / shares	98.47
Vested (in dollars per share) \| $ / shares	186.03
Cancelled/forfeited (in dollars per share) \| $ / shares	159.55
Ending balance (in dollars per share) \| $ / shares	$ 119.88

Stockholders_ Equity and Equi_6

Stockholders’ Equity and Equity Incentive Plans - Summary of Stock-based Compensation Expense by Line Item (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 302,815	$ 114,801	$ 767,693	$ 315,912
Benefit from income taxes	(53,995)	0	(151,027)	0
Total stock-based compensation expense recorded to net income	248,820	114,801	616,666	315,912
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	41,449	17,206	109,776	46,050
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	83,202	27,879	208,654	71,615
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	125,144	54,220	329,100	156,888
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 53,020	$ 15,496	$ 120,163	$ 41,359

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Income before provision for income taxes	$ 54,749	$ 410,283	$ 288,820	$ 963,098
Provision for income taxes	$ 6,396	$ 69,900	$ 81,059	$ 78,100
Effective tax rate	11.70%	17%	28.10%	8.10%

Net Income Per Share Attribut_3

Net Income Per Share Attributable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Numerator:
Net income	$ 48,353	$ 340,383	$ 207,761	$ 884,998
Net income attributable to common stockholders	$ 48,353	$ 340,271	$ 207,744	$ 884,568
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	295,537,026	297,375,011	297,765,848	295,647,626
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	301,986,341	305,939,624	305,273,812	305,726,733
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.16	$ 1.14	$ 0.70	$ 2.99
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.16	$ 1.11	$ 0.68	$ 2.89
Class A Common Stock
Numerator:
Net income	$ 40,726	$ 276,024	$ 174,835	$ 707,188
Less: undistributed earnings attributable to participating securities	0	0	0	0
Net income attributable to common stockholders	40,726	276,024	174,835	707,188
Reallocation of net income attributable to common stockholders	(568)	(5,756)	(2,516)	(15,965)
Net income attributable to common stockholders, diluted	$ 40,158	$ 270,268	$ 172,319	$ 691,223
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	248,917,590	241,227,457	250,595,877	236,362,585
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	250,803,759	243,024,399	253,217,436	238,904,473
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.16	$ 1.14	$ 0.70	$ 2.99
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.16	$ 1.11	$ 0.68	$ 2.89
Class B Common Stock
Numerator:
Net income	$ 7,627	$ 64,359	$ 32,926	$ 177,810
Less: undistributed earnings attributable to participating securities	0	(112)	(17)	(430)
Net income attributable to common stockholders	7,627	64,247	32,909	177,380
Reallocation of net income attributable to common stockholders	568	5,756	2,516	15,965
Net income attributable to common stockholders, diluted	$ 8,195	$ 70,003	$ 35,425	$ 193,345
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	46,619,436	56,147,554	47,169,971	59,285,041
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	51,182,582	62,915,225	52,056,376	66,822,260
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.16	$ 1.14	$ 0.70	$ 2.99
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.16	$ 1.11	$ 0.68	$ 2.89

Net Income Per Share Attribut_4

Net Income Per Share Attributable to Common Stockholders - Summary of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders (Details) - shares	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	15,262,056	1,401,165	9,194,453	757,558
Class A Common Stock \| Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	12,741,748	816,953	7,656,321	473,104
Class A Common Stock \| Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	2,395,761	584,212	1,462,148	284,454
Class A Common Stock \| Outstanding stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	124,547	0	75,984	0
Class A Common Stock \| Held For Charitable Contributions
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)			405,156	405,156
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B Common Stock \| Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B Common Stock \| Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B Common Stock \| Outstanding stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0